Allena Pharmaceuticals
ALNA
ALNA was delisted on the 7th of September, 2022.
30 hedge funds and large institutions have $10.1M invested in Allena Pharmaceuticals in 2021 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 7 increasing their positions, 8 reducing their positions, and 9 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
13% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 8
17% less funds holding
Funds holding: 36 → 30 (-6)
44% less capital invested
Capital invested by funds: $18M → $10.1M (-$7.9M)
56% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 9
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1M |
| 2 |
VF
Virtu Financial
New York
|
+$105K |
| 3 |
KAS
Kestra Advisory Services
Austin,
Texas
|
+$44.2K |
| 4 |
SWM
Spire Wealth Management
Mclean,
Virginia
|
+$32.8K |
| 5 |
LFAS
Level Four Advisory Services
Dallas,
Texas
|
+$31.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FM
Frazier Management
Seattle,
Washington
|
-$1.31M |
| 2 |
ACM
Altium Capital Management
New York
|
-$963K |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$822K |
| 4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$138K |
| 5 |
Renaissance Technologies
New York
|
-$120K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Victory Capital Management
San Antonio,
Texas
| $7K | -$7 | -9 | -0.1% |
|
27
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| $6K | +$7.82K | +10,000 | New |
|
28
Bank of America
Charlotte,
North Carolina
| $3K | -$78 | -100 | -2% |
|
29
Wells Fargo
San Francisco,
California
| $1K | +$1.2K | +1,529 | +107% |
|
|
ACM
30
Altium Capital Management
New York
| – | -$963K | -1,067,886 | Closed |
|
|
GCP
31
GSA Capital Partners
London,
United Kingdom
| – | -$138K | -152,731 | Closed |
|
|
32
Renaissance Technologies
New York
| – | -$120K | -132,700 | Closed |
|
|
TSS
33
Two Sigma Securities
New York
| – | -$76K | -83,689 | Closed |
|
|
QP
34
Quilter Plc
London,
United Kingdom
| – | -$47K | -52,204 | Closed |
|
|
ECM
35
ExodusPoint Capital Management
New York
| – | -$42K | -46,713 | Closed |
|
|
XT
36
XTX Topco
George Town,
Cayman Islands
| – | -$19K | -21,443 | Closed |
|
|
HI
37
Harbour Investments
Madison,
Wisconsin
| – | -$5K | -6,000 | Closed |
|
|
TRCT
38
Tower Research Capital (TRC)
New York
| – | -$5K | -5,189 | Closed |
|
|
TC
39
TAP Consulting
Kirkwood,
Missouri
| – | +$23 | +30 | New |
|
ALNA Hedge Fund Activity: Q4 2021 in Review
30 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in Allena Pharmaceuticals (ALNA) for Q4 2021, worth a combined $10.1M — down 44% from $18M a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of ALNA and 4 opened new positions — a net loss of 5 holders — while 8 trimmed existing stakes and 7 added.
The largest buyer was Vanguard Group, adding an estimated $1M. The largest seller was Frazier Management, cutting an estimated $1.31M.
- 30 institutional investors held Allena Pharmaceuticals (ALNA) as of Q4 2021, down from 36 in Q3 2021.
- Funds reported $10.1M of Allena Pharmaceuticals stock for Q4 2021, down 44% quarter-over-quarter.
- 4 funds opened new Allena Pharmaceuticals positions in Q4 2021 and 9 closed out, a net change of -5 holders.
- The largest Allena Pharmaceuticals buyer in Q4 2021 was Vanguard Group, an estimated $1M added.
- The largest Allena Pharmaceuticals seller in Q4 2021 was Frazier Management, an estimated $1.31M sold.
Based on aggregated 13F filings for Q4 2021.